Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease

Cardiovascular Drugs and Therapy

Volumn 8, Issue 5, 1994, Pages 741-747

  Hayashida, Wataru ^a   van Eyll, Christian ^a   Rousseau, Michel F ^a   Pouleur, Hubert ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

diastolic function; hibernating myocardium; ischemic heart disease; ranolazine; regional wall motion

Indexed keywords

MEGLUMINE DIATRIZOATE PLUS SODIUM DIATRIZOATE; RANOLAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE PERFORMANCE; HEART LEFT VENTRICLE RELAXATION; HEART LEFT VENTRICLE WALL; HEMODYNAMICS; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANGINA PECTORIS; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PIPERAZINES; VENTRICULAR FUNCTION, LEFT;

EID: 0028134824     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/BF00877121     Document Type: Article

References (21)

1. The effects of the novel anti-anginal agent RS 43285 on [lactic acid], [K+] and pH in a canine model of transient myocardial ischaemia
2. Pharmacological profile of ranolazine, a metabolic modulator active in ischaemia
3. Prevention of myocardial enzyme release by ranolazine in a primate model of ischemia with reperfusion
4. Metabolic regulation in ischemia and hypoxia. Effects of regional ischemia on metabolism of glucose and fatty acids. Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia
5. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with β-blocker or diltiazem
6. Analysis of the mechanisms underlying the changes in left ventricular filling dynamics during oral nisoldipine therapy in patients with anterior myocardial infarction
7. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: Modification by long-term enalapril treatment
8. Left ventricular regional relaxation and its nonuniformity in hypertrophic nonobstructive cardiomyopathy
9. Assessment of regional left ventricular relaxation in patients with coronary artery disease: Importance of geometric factors and changes in wall thickness
10. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure
11. Reversible ischemic left ventricular dysfunction: Evidence for the “hibernating myocardium”
12. Cardiac hypertrophy: Consequences for diastole
13. Triple control of relaxation: Implications in cardiac disease
14. Determinants of left ventricular filling and of the diastolic pressure-volume relation
15. Left ventricular filling dynamics: Influence of left ventricular relaxation and left atrial pressure
16. Ranolazine—A new drug with beneficial effects on renal preservation
17. Global ischemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-prefusion protects against ischaemic damage
18. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction